1. Stocks
    2. /
  2. Opthea (ASX: OPT)
    3. /

Opthea (ASX: OPT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Opthea Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Opthea (ASX: OPT)
    Latest News

    Disappointed man with his head on his hand looking at a falling share price his a laptop.
    Share Fallers

    Why IperionX, Northern Star, Opthea, and Superloop shares are tumbling today

    | James Mickleboro

    These shares are out of form and taking a dive today. But why?

    Read more »

    Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
    Share Fallers

    Why Catapult Sports, Harvey Norman, Inghams, and Opthea shares are sinking today

    | James Mickleboro

    These shares are having a tough time on hump day. Let's find out why.

    Read more »

    A man stands in front of a chart with an arrow going down and slaps his forehead in frustration.
    Healthcare Shares

    Why is this ASX share crashing 97% today?

    | James Mickleboro

    It isn't often that a share falls by this amount in a single session.

    Read more »

    Scientists working in the laboratory and examining results.
    Healthcare Shares

    Broker laments 'catastrophic negative surprise' that highlights the risks with these types of ASX shares

    | Bronwyn Allen

    Canaccord Genuity recommends a 'basket approach' when investing in these types of stocks.

    Read more »

    A worried woman looks at her phone and laptop, seeking ways to tighten her belt against inflation.
    Healthcare Shares

    This ASX share potentially 'has no value from here', says broker

    | Bronwyn Allen

    This is every investor's worst nightmare.

    Read more »

    Man smiling at a laptop because of a rising share price.
    Dividend Investing

    Why this sold-off ASX All Ords dividend stock is 'well placed to generate long-term shareholder value'

    | Bernd Struben

    A leading expert sees long-term value in this beaten-down ASX All Ords dividend stock.

    Read more »

    Shot of a mature scientists working on a laptop in a lab.
    Healthcare Shares

    Amid fears of collapse, what's happening with Opthea ASX shares today?

    | Bronwyn Allen

    A failed clinical trial has rattled investors.

    Read more »

    A young boy wearing a hat, sunnies and striped singlet looks fierce and flexes his arm in victory.
    Broker Notes

    Experts reveal 4 ASX small-cap shares to buy now

    | Bronwyn Allen

    ASX small-cap shares are slightly outperforming the broader market in 2025.

    Read more »

    A young man wearing a black and white striped t-shirt looks surprised.
    Speculative

    Why this speculative ASX stock could rocket 70%

    | James Mickleboro

    Investors with a high tolerance for risk might want to take a look at the speculative ASX stock in this…

    Read more »

    A man clenches his fists in excitement as gold coins fall from the sky.
    Share Gainers

    Why Capricorn Metals, IDP Education, Life360, and Opthea shares are storming higher

    | James Mickleboro

    These shares are having a good session on Tuesday. But why? Let's find out.

    Read more »

    A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
    Share Fallers

    Why Healius, Opthea, Peninsula Energy, and Wildcat shares are falling today

    | James Mickleboro

    These shares are having a tough finish to the week. But why?

    Read more »

    Two happy scientists analysing test results.
    52-Week Highs

    3 ASX All Ords health care shares that reached 52-week peaks today

    | Bronwyn Allen

    These health care companies finished the week on a positive note.

    Read more »

    Frequently Asked Questions

    No, Opthea does not pay shareholder dividends at this time.

    Opthea Limited listed on the ASX on 18 April 1991. 

    OPT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Opthea

    Opthea Limited (ASX: OPT) is a clinical-stage biopharmaceutical company. Following the failure of its Phase 3 wet age-related macular degeneration (AMD) trials, the company discontinued that program and relaunched in June 2026 with a new focus on OPT-302 as a potential treatment for lymphangioleiomyomatosis (LAM), a rare lung disease.

    Shareholders have been asked to approve a proposed name change to Ceryvyn Therapeutics to reflect the new direction.

    OPT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    08 Jul 2026 $0.01 $0.00 0.00% 7,777,329 $0.01 $0.02 $0.01
    07 Jul 2026 $0.01 $0.00 0.00% 4,723,387 $0.02 $0.02 $0.01
    06 Jul 2026 $0.02 $0.00 0.00% 9,873,809 $0.02 $0.02 $0.01
    03 Jul 2026 $0.01 $0.00 0.00% 3,708,050 $0.02 $0.02 $0.01
    02 Jul 2026 $0.02 $0.00 0.00% 19,796,064 $0.02 $0.02 $0.01
    01 Jul 2026 $0.01 $0.00 0.00% 27,096,878 $0.02 $0.02 $0.01
    30 Jun 2026 $0.02 $0.00 0.00% 22,466,638 $0.01 $0.02 $0.01

    Profile

    since

    Note